Reported 2 days ago
Investors are hopeful for a Santa Claus rally this year, with three stocks making the list: AbbVie, Novo Nordisk, and Vertex Pharmaceuticals. AbbVie, despite a recent setback with its schizophrenia drug, presents a buying opportunity due to its promising pipeline and solid valuation. Novo Nordisk has faced a decline but shows potential for significant growth through its diabetes and obesity treatments. Vertex Pharmaceuticals, though recently impacted by clinical study results, is expecting two FDA approvals soon, which could lead to a rebound. These stocks are considered valuable investments as the year comes to a close.
Source: YAHOO